PFK Inhibitors

Santa Cruz Biotechnology now offers a broad range of PFK Inhibitors for use in various applications. PFK Inhibitors are essential tools for studying phosphofructokinase (PFK), a key regulatory enzyme in the glycolytic pathway. PFK catalyzes the phosphorylation of fructose-6-phosphate to fructose-1,6-bisphosphate, a crucial step in glycolysis that controls the rate of glucose metabolism. By inhibiting PFK, researchers can modulate glycolytic flux and investigate the metabolic and regulatory mechanisms governing cellular energy production. These inhibitors are invaluable for exploring how cells adjust their metabolic pathways in response to varying energy demands and environmental conditions. In scientific research, PFK Inhibitors are used to study the intricate regulation of glycolysis and its impact on cellular physiology, including ATP production, biosynthesis, and redox balance. Researchers employ these inhibitors to understand how metabolic reprogramming occurs in different cell types, such as during cellular differentiation, proliferation, and stress responses. Additionally, PFK Inhibitors are used in metabolic flux analysis to quantify changes in metabolic pathway activities under various experimental conditions. These inhibitors help explain the role of glycolysis in overall cellular metabolism and its interactions with other metabolic pathways, such as the tricarboxylic acid (TCA) cycle and oxidative phosphorylation. By providing insights into the regulation of PFK and glycolysis, these inhibitors support the development of new research methodologies and enhance our understanding of cellular metabolism. View detailed information on our available PFK Inhibitors by clicking on the product name.